Colorectal cancer (CRC) is among the leading causes of new cancer diagnoses and cancer-related deaths in the U.S.[1] Some groups have increased risk of being diagnosed with and dying from colorectal cancer, including marginalized racial/ethnic groups [2-6], rural residents [7-9], and those in low socioeconomic areas [10-11]. However, there is limited research on colorectal cancer for those who intersect these characteristics [12-31]. In Aim 1, we looked at patterns in colorectal cancer diagnosis and cancer-related mortality. Non-Hispanic Black patients had higher rates of stage III and IV colorectal cancer diagnosis, and non-Hispanic Black and non-Hispanic American Indian/Alaska Native patients had higher rates of cancer-related mortality compared to non-Hispanic White. We recommend future studies assess how screening impacts diagnosis and mortality for these groups. In Aim 2, we assessed time from colorectal cancer diagnosis to treatment and receipt of guideline-recommended care between intersection groups of race/ethnicity and rurality. Non- White patients in rural areas were more likely to start colon cancer treatment more than one month after diagnosis; non-White patients in urban areas were more likely to start rectal cancer treatment more than one month after diagnosis. We recommend that future studies identify unique mechanisms that impact time to treatment for these groups. In Aim 3, we examined survival for all intersection groups at two years and five years after diagnosis. Non-Hispanic Black and non-Hispanic American Indian/Alaska Native patients in rural/high poverty areas had worse survival at all time points compared to those in urban/high poverty, rural/low poverty, and urban/low poverty areas. Future studies should study how screening and treatment impact these relationships.